Publication | Closed Access

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial

AsthmaMild AsthmaAllergyCardiovascular DiseaseMyocardial Perfusion ImagingModerate Asthma PatientsMyocardial InfarctionCardiovascular PharmacologyPulmonary PharmacologyPharmacotherapyPublic HealthMedicineCardiologyAnesthesiologyCardiovascular Imaging